Product logins

Find logins to all Clarivate products below.


: Bioworld

Here you will find relevant articles and insight into all Clarivate related products and news.

Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Biopharma Bioworld Business Development
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Biopharma Bioworld Business Development
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Biopharma Bioworld Business Development
Blog September 1, 2018
FDA draft guidance addresses inclusion of adolescents in oncology trials
Bioworld BioWorld MedTech Clinical trials
Blog July 12, 2018
European biotech on course for record year with $3.9B raised in first half of 2018
Biopharma Bioworld Cortellis
Blog July 10, 2018
Biopharma IPOs gone wild: Highest amount ever raised as 14 companies join public ranks
Biopharma Bioworld Cortellis
Blog June 11, 2018
BioWorld recognized for excellence in journalism by Specialized Information Publishing Association
Bioworld BioWorld MedTech Cortellis
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Biopharma deals Bioworld Cortellis

Bioworld

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Blog September 1, 2018
FDA draft guidance addresses inclusion of adolescents in oncology trials
Blog July 12, 2018
European biotech on course for record year with $3.9B raised in first half of 2018
Blog July 10, 2018
Biopharma IPOs gone wild: Highest amount ever raised as 14 companies join public ranks
Blog June 11, 2018
BioWorld recognized for excellence in journalism by Specialized Information Publishing Association
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Blog February 22, 2018
Cancer, neurology, immune therapies drive continued robust pace of biopharma financings